Jasmine Kway

CEO Volition Asia
VolitionRX

​​Dr Jasmine Kway is the Chief Executive Officer of Volition and oversees the group's operations in Asia Pacific. She has built strong partnerships for clinical trials and commercial advancements for Volition's innovative family of simple, easy to use, cost-effective Nu.Q® and Nu.Q® NETs cancer diagnostic tests.  Jasmine has a Bachelor of Engineering and a Doctor of Philosophy in Oceanography from the National University of Singapore.

Volition is a multi-national epigenetics company focused on advancing the science of epigenetics. Volition is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Here's a short video bio of Jasmine
https://vimeo.com/510237480

 

Speech title & Synopsis

Revolutionizing the diagnosis and monitoring of diseases by advancing the science of epigenetics - Volition’s nucleosome quantification technology (Nu.Q®)

.